# The fetal frontier: A review of current and emerging fetal therapies for genetic diseases — GCMD Library Lizzy Lee from Cincinnati Children's discusses a pivotal review on 'The Fetal Frontier,' highlighting emerging therapies for genetic diseases. This video explores the innovative approaches of treating genetic conditions in the womb, leveraging advantages like a more tolerant fetal immune system. Learn about prenatal diagnosis and potential treatments including maternal medications, enzyme replacement therapy, protein therapy, and stem cell interventions to prevent lifelong diseases. Colton G. Brown, Marissa Ray, Marco Carpenter, Braxton Forde, Tarun Subramanian, Haley Temple, Shivendra Tenguria, Laura Galganski Abstract Pivotal advancements in diagnostics have greatly improved early detection of disease in the fetus. Rapid diagnosis of prenatal disease, including many aneuploidies and single-gene disorders, is now possible. These capabilities present an opportunity for earlier interventions and involvement of multidisciplinary care for infants discovered to have genetic disorders. While advancements continue to be made surgically addressing anatomic pathologies, more recently, the scope of fetal medicine has expanded to include the treatment of genetic disease. This unique and growing group of conditions with potential prenatal therapeutic targets spans broadly to include inborn errors of metabolism, neurodegenerative disorders, hematologic conditions, and errors in hormone biosynthesis. Because many of these hereditary conditions begin exerting deleterious effects before birth, prenatal therapies are critical to minimize or potentially avoid postnatal consequences. Fetal treatments can leverage the benefits of early human development such as a selectively permissive blood-brain barrier and a naive immune system. These factors, along with a favorable vector-to-tissue mass ratio in the fetus, create ideal treatment conditions that are not present after birth. Together, improved prenatal diagnostics and safe minimally invasive approaches for the delivery of therapies in utero have opened a window to what was previously an inaccessible population: the fetal patient. This review summarizes current clinical strategies and emerging investigational approaches, including enzyme replacement, protein therapy, stem cell transplantation, and gene-targeted interventions. Type: video · 0 min · posted 2026-05-18 Canonical: https://library.globalcastmd.com/watch/the-fetal-frontier-a-review-of-current-and-emerging-fetal-therapies-for-genetic-diseases-12057 ## Chapters - [0:00](https://library.globalcastmd.com/watch/the-fetal-frontier-a-review-of-current-and-emerging-fetal-therapies-for-genetic-diseases-12057?t=0) Fetal Therapies for Genetic Diseases ## Statements - "Faster prenatal diagnosis enables detection of many genetic conditions early" — Lizzie Lee (clinical) [0:14](https://library.globalcastmd.com/watch/the-fetal-frontier-a-review-of-current-and-emerging-fetal-therapies-for-genetic-diseases-12057?t=14) - "Medications can be given to the mother that cross the placenta" — Lizzie Lee (clinical) [0:18](https://library.globalcastmd.com/watch/the-fetal-frontier-a-review-of-current-and-emerging-fetal-therapies-for-genetic-diseases-12057?t=18) - "Enzyme replacement therapy can be delivered directly to the fetus" — Lizzie Lee (clinical) [0:18](https://library.globalcastmd.com/watch/the-fetal-frontier-a-review-of-current-and-emerging-fetal-therapies-for-genetic-diseases-12057?t=18) - "Protein therapy can be delivered to the fetus" — Lizzie Lee (clinical) [0:24](https://library.globalcastmd.com/watch/the-fetal-frontier-a-review-of-current-and-emerging-fetal-therapies-for-genetic-diseases-12057?t=24) - "Stem cells can be delivered to the fetus" — Lizzie Lee (clinical) [0:24](https://library.globalcastmd.com/watch/the-fetal-frontier-a-review-of-current-and-emerging-fetal-therapies-for-genetic-diseases-12057?t=24) - "The fetus has a more tolerant immune system compared to postnatal life" — Lizzie Lee (clinical) [0:27](https://library.globalcastmd.com/watch/the-fetal-frontier-a-review-of-current-and-emerging-fetal-therapies-for-genetic-diseases-12057?t=27) - "The fetus has a more permissive blood-brain barrier compared to postnatal life" — Lizzie Lee (clinical) [0:27](https://library.globalcastmd.com/watch/the-fetal-frontier-a-review-of-current-and-emerging-fetal-therapies-for-genetic-diseases-12057?t=27) - "Most fetal therapies for genetic diseases are still experimental" — Lizzie Lee (clinical) [0:34](https://library.globalcastmd.com/watch/the-fetal-frontier-a-review-of-current-and-emerging-fetal-therapies-for-genetic-diseases-12057?t=34) - "Fetal intervention aims to prevent lifelong disease by treating during fetal development" — Lizzie Lee (clinical) [0:38](https://library.globalcastmd.com/watch/the-fetal-frontier-a-review-of-current-and-emerging-fetal-therapies-for-genetic-diseases-12057?t=38) ## Transcript What if we could treat genetic diseases before a baby is even born? I'm Lizzie Lee from Cincinnati Children's, and this is an article you should know about. This new review highlights a growing frontier in fetal medicine, treating genetic disease in the womb. With faster prenatal diagnosis, doctors can now detect many genetic conditions early. Some approaches are giving medications to the mother that cross the placenta, delivering enzyme replacement therapy. Directly to the fetus and even protein therapy and stem cells. The fetus actually has some advantages for treatment, a more tolerant immune system and a more permissive blood-brain barrier. Most of these treatments are still experimental, but the idea is powerful. Intervene during fetal development to prevent lifelong disease. Let us know what you think and stay tuned for more articles that you should know about. --- Not medical advice · citation policy: https://library.globalcastmd.com/ai